The Healthy Man Study: Development of Valid Diagnostic Criteria for Age-related Androgen Deficiency in Me
Not Applicable
Completed
- Conditions
- androgen levelMetabolic and Endocrine - Normal metabolism and endocrine development and function
- Registration Number
- ACTRN12608000290392
- Lead Sponsor
- mbf foundation (Medical benefits fund foundation)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 400
Inclusion Criteria
self-assessment of being in very good or excellent health. The participants will be stratified in the age groups 40-50, 50-60, 60-70, over 70 years.
Exclusion Criteria
- self-assessment of not being in very good or excellent health
- medication which influences androgen metabolism
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reference ranges for testosterone in aging men, measured in serum samples using the LCMS method (liquid chromatography/ mass spectrometry).[5 sampling days over three months(visit 1: day 0, visit 2: between day 2-4, visit 3: between day 5-12, visit 4: between day 20-40, visit 5: between day 80-100. At visit 1 and 2 three blood samples will be taken every 20-60 minutes. At visits 3-5 only one blood sample will be taken).]
- Secondary Outcome Measures
Name Time Method evaluating the variability of testosterone levels in healthy men using LCMS measurements of serum samples at different timepoints of sampling[Intraday, interday, interweek, intermonth variability (visit 1: day 0, visit 2: between day 2-4, visit 3: between day 5-12, visit 4: between day 20-40, visit 5: between day 80-100. At visit 1 and 2 three blood samples will be taken every 20-60 minutes. At visits 3-5 only one blood sample will be taken).]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are implicated in age-related androgen deficiency as studied in ACTRN12608000290392?
How do the diagnostic criteria from ACTRN12608000290392 compare to serum testosterone thresholds in identifying androgen deficiency in aging men?
Which biomarkers correlate with metabolic/endocrine profiles in ACTRN12608000290392 for age-related androgen deficiency?
What adverse events are associated with testosterone replacement therapy in men with age-related androgen deficiency?
Are there combination therapies or alternative compounds being explored for age-related androgen deficiency alongside ACTRN12608000290392 criteria?